```html

Quincke Edema (Angioedema)

What is Quincke edema (angioedema)?

Quincke edema, more commonly called angioedema, is a sudden, localized swelling of the deeper layers of the skin or mucous membranes. Unlike hives (urticaria), which affect the superficial dermis and appear as itchy, raised wheals, angioedema involves the deeper subcutaneous tissue, submucosal tissue, or even the subserosal layers of the gastrointestinal tract.

The swelling is caused by increased vascular permeability that allows fluid to leak into the interstitial space. It can affect the face, lips, tongue, throat, eyelids, genitals, hands, feet, and, in severe cases, the airway. When the swelling occurs in the larynx or tongue, it can become a life‑threatening emergency because it may obstruct breathing.

The term “Quincke edema” honors Heinrich Quincke, a German physician who first described the condition in 1882.

Common Causes

Angioedema is a reaction pattern rather than a single disease. The most frequent triggers fall into several categories:

• Allergic (IgE‑mediated) reactions – foods (e.g., peanuts, shellfish), insect stings, latex, or medications such as penicillins.
• Drug‑induced non‑allergic angioedema – especially ACE inhibitors (e.g., lisinopril, enalapril) and, less commonly, ARBs, NSAIDs, and certain antibiotics.
• Hereditary angioedema (HAE) – a rare autosomal dominant disorder caused by C1‑esterase inhibitor deficiency or dysfunction.
• Acquired C1‑esterase inhibitor deficiency – often associated with lymphoproliferative disorders or autoimmune disease.
• Idiopathic angioedema – no identifiable trigger after thorough evaluation.
• Physical triggers – pressure, temperature extremes, sunlight (solar urticaria), or vibration.
• Infections – viral (e.g., hepatitis C), bacterial, or parasitic infections can precipitate angioedema in some individuals.
• Autoimmune diseases – systemic lupus erythematosus, thyroid disease, and vasculitis may be associated.
• Stress‑related or hormonal factors – menstrual cycle fluctuations, pregnancy, or emotional stress can modulate mast‑cell activity.
• Food additive sensitivities – sulfites, monosodium glutamate (MSG), and certain preservatives.

Associated Symptoms

Angioedema rarely occurs in isolation. Patients often experience other clinical features that help pinpoint the underlying cause:

• Urticaria (hives) – red, itchy wheals that may appear minutes to hours before or after swelling.
• Pruritus (itching) – especially with allergic angioedema.
• Abdominal pain, nausea, vomiting, or diarrhea – can result from swelling of the gastrointestinal submucosa (common in HAE).
• Difficulty swallowing (dysphagia) or a sensation of “tight throat” – indicates involvement of the oropharynx.
• Hoarseness or voice changes – laryngeal edema.
• Skin tightness or a “painless” swelling – non‑pruritic swelling is typical of ACE‑inhibitor or hereditary forms.
• Low blood pressure or faintness – may accompany anaphylaxis.

When to See a Doctor

Most cases of angioedema are self‑limited, but certain signs warrant prompt medical evaluation:

• Swelling of the lips, tongue, or throat that makes speaking or swallowing difficult.
• Rapidly spreading facial or neck swelling.
• Shortness of breath, wheezing, or a feeling of choking.
• Hives accompanied by dizziness, fainting, or a rapid pulse – possible anaphylaxis.
• Repeated episodes without an obvious trigger (consider hereditary or acquired C1‑esterase deficiency).
• Abdominal pain with vomiting or severe diarrhea lasting more than a few hours.
• Any swelling after starting a new medication, especially ACE inhibitors.

If any of these symptoms appear, seek care immediately—preferably at an emergency department.

Diagnosis

Diagnosing angioedema involves a combination of clinical assessment, laboratory work‑up, and sometimes imaging.

Clinical History & Physical Exam

• Onset, duration, and pattern of episodes.
• Potential triggers (food, drugs, insect bites, stress).
• Family history of similar swelling (suggests HAE).
• Associated symptoms (urticaria, abdominal pain, respiratory signs).
• Medication review, especially ACE inhibitors, ARBs, NSAIDs.

Laboratory Tests

• C4 complement level – low in most cases of hereditary or acquired C1‑esterase inhibitor deficiency.
• C1‑esterase inhibitor (C1‑INH) quantity and function – differentiates type I (low level) from type II (dysfunctional) HAE.
• Serum tryptase – elevated in mast‑cell mediated (IgE) angioedema; helps distinguish from bradykinin‑mediated forms.
• CBC, CMP – to rule out infection, renal or hepatic dysfunction.
• Specific IgE or skin prick testing – if an allergic trigger is suspected.

Imaging (when indicated)

• Neck X‑ray or CT scan – evaluate airway patency if laryngeal edema is suspected.
• Abdominal ultrasound or CT – for severe abdominal pain when gastrointestinal angioedema is considered.

Specialist Referral

Allergists/immunologists manage allergic and hereditary forms, while otolaryngologists (ENT) may be consulted for persistent airway involvement.

Treatment Options

Treatment depends on the underlying mechanism (mast‑cell vs. bradykinin mediated) and severity.

Acute Management

• Airway protection – the first priority. If there is any compromise, administer high‑flow oxygen and be prepared for intubation or surgical airway (cricothyrotomy).
• Allergic (IgE‑mediated) angioedema
  • Intramuscular epinephrine 0.3 mg (1:1000) – repeat every 5–15 minutes if symptoms persist.
  • Antihistamines: diphenhydramine 25–50 mg IV/PO; H1 blockers.
  • Corticosteroids: methylprednisolone 125 mg IV or prednisone 40–60 mg PO – helps prevent late‑phase reaction.
  • Consider nebulized epinephrine for laryngeal edema.
• Bradykinin‑mediated angioedema (ACE‑inhibitor, HAE, acquired C1‑INH deficiency)
  • Discontinue the offending ACE inhibitor immediately.
  • For HAE attacks:
    • C1‑INH concentrate (Berinert®, Cinryze®) 20 U/kg IV.
    • Icatibant (Firazyr®) 30 mg SC – a bradykinin‑2 receptor antagonist.
    • Ecallantide (Kalbitor®) 30 mg SC – kallikrein inhibitor.
  • Fresh frozen plasma (FFP) can be used as a temporary measure if specific therapy is unavailable (contains C1‑INH).

Long‑Term Management

• Allergic angioedema
  • Avoid known allergens; carry an epinephrine auto‑injector (EpiPen®) if reactions are severe.
  • Daily antihistamines (cetirizine, loratadine) for chronic urticaria‑associated angioedema.
• ACE‑inhibitor–induced angioedema
  • Switch to an ARB (some patients tolerate) or another antihypertensive class.
• Hereditary or Acquired C1‑INH deficiency
  • Prophylactic C1‑INH replacement (IV or SC) 1–2 times per week.
  • Androgen therapy (danazol, stanozolol) – less used now because of side‑effects.
  • Regular follow‑up with an immunology specialist.
• Idiopathic chronic angioedema
  • High‑dose second‑generation antihistamines (up to 4× standard dose).
  • Consider omalizumab (Xolair®) – anti‑IgE monoclonal antibody, proven effective in refractory cases.

Home Care Measures (for mild episodes)

• Apply a cool compress to reduce swelling.
• Elevate the affected limb or area if possible.
• Stay hydrated; dehydration can exacerbate swelling.
• Avoid known triggers and keep a symptom diary.

Prevention Tips

• Know your triggers – keep a written record of foods, drugs, or environmental exposures that precede attacks.
• Medication review – discuss with your provider whether ACE inhibitors or NSAIDs are necessary; consider alternatives.
• Allergy testing – skin prick or specific IgE testing can confirm food or inhalant allergies.
• Vaccinations – maintain up‑to‑date immunizations (influenza, COVID‑19) to reduce infection‑triggered episodes.
• Stress management – yoga, mindfulness, or counseling may lower frequency of idiopathic attacks.
• Carry emergency medication – patients with a history of severe angioedema should have an epinephrine auto‑injector and a written action plan.
• Regular follow‑up – especially for hereditary or acquired C1‑INH deficiency, to adjust prophylactic dosing.

Emergency Warning Signs

Key Take‑aways

Quincke edema (angioedema) is a potentially serious swelling reaction that can affect the skin, mucous membranes, and internal organs. While many episodes are mild and self‑limited, the condition can rapidly become life‑threatening when the airway is involved. Recognizing triggers, obtaining an accurate diagnosis, and having an emergency action plan are essential steps for patients and providers alike.

For personalized advice, always consult a qualified health professional. The information above is based on current guidelines from the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```